Starling Oncology, Inc.

Starling Oncology, Inc., formerly The Oncology Institute, is a value-based oncology company advancing cancer care in the community setting. Founded in 2007, the company offers cutting-edge, evidence-based cancer treatments, including clinical trials and transfusions, to a large patient population. It operates as an integrated oncology platform serving patients, providers, and health plans across multiple markets with a focus on delivering high-quality, patient-centered care.

行业

Medical - Care Facilities

部门

Healthcare

总部

US

首席执行官

Daniel Virnich

上市以来

2026年8月4日

雇员

641